NeoGenomics (NEO) is currently showing mixed signals on the technical front. The stock closed at $9.93 on March 20, 2025, with a 14-day RSI of 41.85, indicating a neutral to slightly bearish momentum. The MACD is currently at -0.82, suggesting a bearish trend, while the Stochastic Oscillator shows a bearish crossover with StochD (39.30) below StochK (43.15).
The Fibonacci levels indicate a pivot point at $9.95, with support levels at $8.74 and resistance at $10.69. These levels are critical in determining potential price movements in the short term.
Recent news indicates a cautious outlook from analysts, with Piper Sandler lowering the price target to $18 from $21, while maintaining an Overweight rating. Craig-Hallum also maintains a Buy rating with an average price target of $19.20, indicating a potential upside of 42.43% from current levels.
Based on the technical indicators and analyst sentiment, the stock is expected to face resistance at the $10.69 level and support at $8.74. Considering the current price of $9.93 and the bearish technical indicators, the stock is likely to trade sideways to slightly down in the next trading week.
Given the current technical setup and mixed analyst sentiment, it is recommended to sell NeoGenomics (NEO) at the current price of $9.93, with a target price of $9.50 for the next trading week.
The price of NEO is predicted to go up 55.26%, based on the high correlation periods with SKY. The similarity of these two price pattern on the periods is 98.1%.
NEO
SKY
Piper Sandler
2025-02-26
Price Target
$21 → $18
Upside
+73.08%
Benchmark
2025-01-16
Price Target
n/a
Downside
0%
Benchmark
2025-01-13
Price Target
n/a
Downside
0%